WE INVITE YOU TO ATTEND SATELLITE SYMPOSIA OF OUR PARTNERS
Thea SATELLITE SYMPOSIUM
Lunch satellite from Thea: «A kaleidoscope of clinical cases in ophthalmology: working on mistakes»
WEDNESDAY, 24 MAY 2023, 12.00-13.00
- Complicated cases of corneal damage: algorithm of actions – Drozhzhyna G.I., Odesa, Ukraine
- Is it possible to prevent a gloomy future with AMD? – Lutsenko N.S., Zaporizhzhya, Ukraine
- Treatment of Ocular Rosacea. Correction of mistakes – Deriapa I.V., Kyiv, Odesa
ALCON SATELLITE SYMPOSIUM
Challenges of vitreoretinal surgery and technologies for their solution
WEDNESDAY, 24 MAY 2023, 15.30-16.30
- Fovea-preserving technique for removing the internal limiting membrane in the treatment of full-thickness macular holes – Umanets M.M., Odesa, Ukraine
- Transciliary vitrectomy with ultrasound-guided phaco-fragmentation in luxated cataracts – Ulyanova N.A., Odesa, Ukraine
- Vasoproliferative tumour. On the edge of the possible – Levytska H.V., Odesa, Ukraine
- Minimally invasive approach to the removal of intraocular foreign bodies in combat eye injuries – Sidak-Petretska O.S., Odesa, Ukraine
ROCHE SATELLITE SYMPOSIUM
Looking beyond anti-VEGF monotherapy in diabetic macular edema and neovascular age-related macular degeneration
THURSDAY, 25 MAY 2023, 12.00-13.00
- The role of angiopoietin 2 in diabetic macular edema and neovascular age-related macular degeneration – Pilkevych T.S., Odesa, Ukraine
- The role of angiopoietin in maintaining vascular stability
- Angiopoietin-2/Tie2 pathway
- Role of Angiopoietin-2 and VEGF-A in vascular stability disorders
2. Results of clinical trials of dual Ang-2 and VEGF-A blockade in diabetic macular edema and neovascular age-related macular degeneration – Korol A.R., Odesa, Ukraine
- Results of phase 3 clinical trials of TENAYA and LUCERNE in neovascular age-related macular degeneration
- Results of phase 3 clinical trials of YOSEMITE and RHINE in diabetic macular edema
BAYER SATELLITE SYMPOSIUM
A decade of aflibersept in Ukraine and the world
THURSDAY, 25 MAY 2023, 15.00-16.00
- Results of randomised clinical trials – Parkhomenko O.G., Kyiv, Ukraine
- Aflibercept in daily practice – Ulyanova N.A., Odesa, Ukraine
- Safety profile and development of the intravitreal technique – Shevchyk V.I., Chernyhiv, Ukraine
- Bayer’s research initiatives and future developments – Korol A.R., Odesa, Ukraine